VAERS Explorer
Back to explore

Report #2853454

Received Aug 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
9 yrs
State
TX
Recovered
Recovered
Vaccinated
Aug 9, 2025
Onset
Aug 9, 2025
Days to onset
0
Hospital days
—

Vaccines (6)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (ENGERIX-B)GLAXOSMITHKLINE BIOLOGICALS43N2NDIM / RA
HEPAHEP A (HAVRIX)GLAXOSMITHKLINE BIOLOGICALS1DN273IM / RA
HPV9HPV (GARDASIL 9)MERCK & CO. INC.1Y010656IM / RA
IPVPOLIO VIRUS, INACT. (IPOL)SANOFI PASTEUR3Y1A212MIM / LA
MMRVMEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)MERCK & CO. INC.2Z003308SC / LA
TDAPTDAP (ADACEL)SANOFI PASTEUR1U8274AAIM / LA

Symptoms (3)

DizzinessPallorVision blurred

Symptom narrative

Patient Presentation & Pre-Vaccination Assessment: Patient presented accompanied by mother and sister for immunizations. Full name and date of birth were verified. Screening for allergies to medications, vaccines, or foods, as well as any underlying medical conditions or contraindications, was negative per the mother. Last food intake was breakfast. After reviewing the patient?s vaccination record, it was determined that 7 vaccines were due: Hepatitis A, Hepatitis B, HPV, Polio, MMRV, and Tdap (6 injections total). The mother was informed of the vaccines, potential adverse reactions, and provided with Vaccine Information Statements. She verbalized understanding and signed informed consent. Vaccination Administration: Vaccines were administered as indicated. The patient appeared anxious prior to vaccination. Adverse Event: Approximately 3 minutes post-vaccination, the patient reported dizziness. Legs were elevated, and an alcohol pad was provided for inhalation. Symptoms improved, and the patient reported feeling better. At 14:41, the patient again reported dizziness and was observed to be pale. Legs were elevated. Vital signs: BP 78/66 mmHg, HR 50 bpm, SpO2 100%, RR 20/min, Temp 97.6°F. The patient stated, ?I no longer see blurry; I feel better.? Repeat vitals at 14:50: BP 78/62 mmHg, HR 73 bpm, SpO2 98%, RR 20/min, Temp 97.6°F. Monitoring & Outcome: Patient was monitored for 22 minutes. At 15:02, vitals were: BP 92/62 mmHg, HR 75 bpm, SpO2 100%, RR 19/min, Temp 98.6°F. She was alert, conscious, oriented, with normal skin color restored. She was instructed to lower her legs slowly and remain seated under observation. Monitored for an additional 15 minutes, during which she was given food and drink. The patient ambulated from the area without complications, accompanied by her parents and sister.

Current illness

None

Medical history

None

Other medications

None

Allergies

None